New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research. It offers restriction endonucleases for DNA digestion; PCR, polymerases, and amplification technologies for PCR applications; DNA modifying enzymes and cloning technologies; reagents for DNA and RNA sample preparation; DNA, RNA, and protein markers and ladders for electrophoresis applications; reagents for RNA research; and gene expression tools for DNA, RNA, and protein transfection of cell lines. The company also offers cellular analysis solutions; reagents, enzymes, antibodies, and DNA controls for epigenetics research; protein expression and purification technologies; competent cells for transformation and protein expression; protein tools; glycobiology products; and plasmids and DNAs for use in cloning experiments. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.

Cellscript LLC is an American private company located in Madison, WI. The firm engages in researching and developing biotechnology.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

C3P3 is the world’s first non-viral, artificial eukaryotic expression system that autonomously synthesizes the messenger RNA (s) of interest (mRNA) in the cytoplasm of the host cell in a high-throughput and efficient manner, allowing high expression of the target proteins. Until late 2000s, the development of an artificial eukaryotic expression system was nearly impossible due to the amazing complexity of eukaryotic post-transcriptional mRNA modifications.

Epicentre, is a manufacturer and seller of high-quality molecular biology products for life science research, clinical research, molecular diagnostics and biopharmaceutical manufacturing. Products are available for RNA amplification and gene expression analysis, transposon-based genetic analysis, DNA and RNA purification, DNA sequencing, PCR and RT-PCR amplification, DNA and RNA modifying enzymes, genomic cloning, in vitro transcription, and protein research and purification. In addition to our broad molecular biology product line, Epicentre also offers custom protein manufacturing.

Suzhou Nearshore Protein Technology Co., Ltd., established on 2009-09-07, Business scope includes technology research and development in the field of biotechnology,Serve,consult,transfer,Transformation of scientific and technological achievements;software(In addition to special products for computer information system security),laboratory reagent(Does not contain dangerous goods),R&D of instrumentation,Sales;In the form of service outsourcing:engaged in the production process,Outsourcing agent for outsourcing processing of products;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China.

Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA.

Wuhan Dangkangxingzhong Biotechnology Co., Ltd., established on 2020-11-26, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Development of Human Gene Diagnosis and Therapy Technology;R&D of industrial enzyme preparations;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Veterinary special instruments and machinery manufacturing;Veterinary special equipment sales;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA. The company develops drugs that are based on Messenger RNA (mRNA) as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. mRNA programs include novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases (RNActive), molecular therapies designed to trigger the body’s own production of therapeutic proteins (RNArt), and RNA encoded antibodies (RNAntibody). Its most advanced product candidate, CV9104, is being developed in Phase IIb for the treatment of prostate cancer.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Suzhou Hanyuan New Enzyme Biotechnology Co., Ltd., established on 2020-10-29, Business scope includes licensed projects:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D of industrial enzyme preparations;Biochemical product technology research and development;Development of Human Gene Diagnosis and Therapy Technology;Specialty Chemicals Sales(Free of Hazardous Chemicals);Research and development of biopesticide technology;Instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Blue Crystal Biotechnology Co., Ltd., established on 2018-06-13, Business scope includes general business items:biotechnology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development;Laboratory equipment development,Installation and technical consulting services;Automation control equipment sales,Installation and technical consulting services;Operating import and export business(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Sell ​​laboratory equipment,biological reagent(Free of Hazardous Chemicals),Chemical products and raw materials(Free of Hazardous Chemicals),electronic product,Software and Auxiliary Equipment;Educational Consulting;Cultural information consultation;Organize cultural and artistic exchange activities(Does not include commercial performances);Exhibition planning;Conference Services.(The above involves national regulations that require approval,Can only operate after obtaining relevant approval documents according to law),The licensing program is:Mechanical and electrical equipment installation engineering,Decoration project.

Kaiyu Biotechnology (Shanghai) Co., Ltd., established on 2018-02-06, Business scope includes biotechnology(remove human stem cells,Development and application of genetic diagnosis and treatment technology),computer technology,Technical services in the field of instrumentation technology,technical consulting,technology development,own technology transfer,Edible produce(paddy,wheat,except corn),Computer hardware,computer software(Audio-visual products,Except for electronic publications),Wholesale of instruments and meters,import and export,commission agent(except auction)and provide related services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

RiboGene is a drug discovery company focused on the identification of novel leads and the development of potential drug candidates for the treatment of infectious diseases. The Company's drug discovery efforts target bacterial, fungal and viral infections for which the efficacy of existing therapies is being threatened by the emergence of drug resistance or for which existing therapies have had limited effectiveness. The Company's drug discovery technology is based on the translational control of gene expression.